Market Overview

UPDATE: ISI Group Raises PT to $27 on Hologic Following Guidance Raise

Share:
Related HOLX
10 Stocks Moving In Wednesday's After-Hours Session
Earnings Scheduled For November 8, 2017
Hologic Inc (HOLX) Files –…-K for the Fiscal Year Ended on September '…, —…–7 (GuruFocus)

ISI Group maintained Hologic (NASDAQ: HOLX) with a Strong Buy rating and raised the price target from $25.50 to $27.00.

ISI Group commented, "Going forward, we expect increased adoption of 3D Tomo (as presaged by the continued sequential backlog increase) and Panther (Diagnostics) to drive growth upside. In the NT, receipt of a potential CMS reimbursement code for 3D Tomo will be a significant catalyst. Given our thesis for a new product cycle accelerating growth, we are reiterating our Strong Buy rating of HOLX shares and raising our price target from $25.50 to $27.00."

Hologic closed at $23.25 on Monday.

Latest Ratings for HOLX

DateFirmActionFromTo
Aug 2017BarclaysMaintainsOverweight
Aug 2017Deutsche BankMaintainsBuy
Aug 2017Goldman SachsMaintainsBuyBuy

View More Analyst Ratings for HOLX
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (HOLX)

View Comments and Join the Discussion!

Partner Center